AU4451601A - Genetically engineered clone of hepatitis e virus (hev) genome which is infectious, its production and uses - Google Patents
Genetically engineered clone of hepatitis e virus (hev) genome which is infectious, its production and usesInfo
- Publication number
- AU4451601A AU4451601A AU44516/01A AU4451601A AU4451601A AU 4451601 A AU4451601 A AU 4451601A AU 44516/01 A AU44516/01 A AU 44516/01A AU 4451601 A AU4451601 A AU 4451601A AU 4451601 A AU4451601 A AU 4451601A
- Authority
- AU
- Australia
- Prior art keywords
- hev
- hepatitis
- infectious
- genome
- virus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 241000724675 Hepatitis E virus Species 0.000 title 1
- 208000015181 infectious disease Diseases 0.000 title 1
- 230000002458 infectious effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/28011—Hepeviridae
- C12N2770/28111—Hepevirus, e.g. hepatitis E virus
- C12N2770/28121—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/28011—Hepeviridae
- C12N2770/28111—Hepevirus, e.g. hepatitis E virus
- C12N2770/28161—Methods of inactivation or attenuation
- C12N2770/28162—Methods of inactivation or attenuation by genetic engineering
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN106DE2000 | 2000-02-07 | ||
IN106/DEL/2000 | 2000-02-07 | ||
PCT/IN2001/000015 WO2001057073A2 (en) | 2000-02-07 | 2001-02-05 | Infectious cdna clone of hepatitis e virus (hev) genome, its production and uses |
Publications (1)
Publication Number | Publication Date |
---|---|
AU4451601A true AU4451601A (en) | 2001-08-14 |
Family
ID=11097025
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU44516/01A Abandoned AU4451601A (en) | 2000-02-07 | 2001-02-05 | Genetically engineered clone of hepatitis e virus (hev) genome which is infectious, its production and uses |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP1169341A1 (en) |
AU (1) | AU4451601A (en) |
WO (1) | WO2001057073A2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2002365931A1 (en) * | 2001-11-09 | 2003-09-02 | The Government Of The United States Of America, As Represented By The Secretary, Department Of Healt | Hepatitis e virus clones and methods of their use |
MX2022001468A (en) | 2019-08-09 | 2022-07-19 | Nutcracker Therapeutics Inc | Methods and apparatuses for manufacturing for removing material from a therapeutic composition. |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996010580A2 (en) * | 1994-10-03 | 1996-04-11 | The Government Of The United States Of America, Re | Recombinant proteins of a pakistani strain of hepatitis e and their use in diagnostic methods and vaccines |
-
2001
- 2001-02-05 AU AU44516/01A patent/AU4451601A/en not_active Abandoned
- 2001-02-05 EP EP01917440A patent/EP1169341A1/en not_active Withdrawn
- 2001-02-05 WO PCT/IN2001/000015 patent/WO2001057073A2/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2001057073A2 (en) | 2001-08-09 |
EP1169341A1 (en) | 2002-01-09 |
WO2001057073A3 (en) | 2002-04-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002230763A1 (en) | Inhibitors of hepatitis c virus ns3 protease | |
AU2001245356A1 (en) | Inhibitors of hepatitis c virus ns3 protease | |
AU2055301A (en) | Alpha-ketoamide inhibitors of hepatitis c virus ns3 protease | |
AU2001280640A1 (en) | Peptides as ns3-serine protease inhibitors of hepatitis c virus | |
AU2001277967A1 (en) | Peptides as ns3-serine protease inhibitors of hepatitis c virus | |
AU2003284689A8 (en) | Nucleic acid construct containing hepatitis c virus (hcv) of genocype 2a genome-origin nucleic acid and cell having the nucleic acid construct transferred thereinto | |
AU2002348151A1 (en) | Viral vector production methods and compositions | |
AU2002346686A1 (en) | Compositions and method for treating hepatitis virus infection | |
AU2003216523A1 (en) | Treatment of pre-core hepatitis b virus mutant infections | |
AU2002225509A1 (en) | Production and of viruses, viral isolates and vaccines | |
HUP0401585A3 (en) | Infectious bovine viral diarrhea virus clone | |
AU2002225895A1 (en) | Hepatitis c virus constructs characterized by high efficiency replication | |
AU2001291162A1 (en) | Production of viral vectors | |
EP1141255A4 (en) | Modified forms of hepatitis c virus ns3 protease | |
AU2001269092A1 (en) | Inhibitors of hepatitis b virus infection | |
WO2001060838A3 (en) | Aids ancestral viruses and vaccines | |
AU4451601A (en) | Genetically engineered clone of hepatitis e virus (hev) genome which is infectious, its production and uses | |
WO2003053332A3 (en) | Composition and method for treating viral infection | |
AU5460900A (en) | Infectious cdna clone of gb virus b and uses thereof | |
AU2003301865A1 (en) | Epitopes of hepatitis c virus | |
EP1521849A4 (en) | Hepatitis a virus nucleotide sequences, recombinant proteins and uses thereof | |
AU2001282560A1 (en) | Methods of infection with hepatitis c virus | |
EP1421222A4 (en) | Cell culture system for synthesis of infectious hepatitis c virus | |
AU2001256675A1 (en) | Method of preparing virus vector | |
AU2001257505A1 (en) | Hepatitis c virus helicase crystals, crystallographic structure and methods |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |